AAAAAA

   
Results: 1-25 |
Results: 25
Role of probiotics in inflammatory bowel disease and intestinal infections
Authors: Gionchetti, P Amadini, C Rizzello, F Venturi, A Romagnoli, R Palmonari, V De Simone, C Campieri, M
Citation: P. Gionchetti et al., Role of probiotics in inflammatory bowel disease and intestinal infections, EXPERT OP T, 11(8), 2001, pp. 1277-1283
Oral versus combination mesalazine therapy in active ulcerative colitis: adouble-blind, double-dummy, randomized multicentre study
Authors: Vecchi, M Meucci, G Gionchetti, P Beltrami, M Di Maurizio, P Beretta, L Ganio, E Usai, P Campieri, M Fornaciari, G De Franchis, R
Citation: M. Vecchi et al., Oral versus combination mesalazine therapy in active ulcerative colitis: adouble-blind, double-dummy, randomized multicentre study, ALIM PHARM, 15(2), 2001, pp. 251-256
Probiotics and antibiotics in inflammatory bowel disease
Authors: Gionchetti, P Rizzello, F Campieri, M
Citation: P. Gionchetti et al., Probiotics and antibiotics in inflammatory bowel disease, CURR OPIN G, 17(4), 2001, pp. 331-335
Pouch dysfunction, inflammation and failure
Authors: Garcia-Aguilar, J Gionchetti, P Rizello, F Amadini, C Venturi, A Campieri, M Blanco, JIF Fazio, VW Sachar, DB
Citation: J. Garcia-aguilar et al., Pouch dysfunction, inflammation and failure, DRUGS TODAY, 37, 2001, pp. 119-120
The role of intestinal flora and value of probiotics in the management of pouchitis
Authors: Gionchetti, P Rizzello, F Amadini, C Venturi, A Romagnoli, R Campieri, M
Citation: P. Gionchetti et al., The role of intestinal flora and value of probiotics in the management of pouchitis, DRUGS TODAY, 37, 2001, pp. 127-133
Bacteria as the cause of ulcerative colitis
Authors: Campieri, M Gionchetti, P
Citation: M. Campieri et P. Gionchetti, Bacteria as the cause of ulcerative colitis, GUT, 48(1), 2001, pp. 132-135
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis
Authors: Kuhbacher, T Gionchetti, P Hampe, J Helwig, U Rosenstiel, P Campieri, M Buhr, HJ Schreiber, S
Citation: T. Kuhbacher et al., Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis, CLIN EXP IM, 123(3), 2001, pp. 395-401
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment
Authors: Ulisse, S Gionchetti, P D'Alo, S Russo, FP Pesce, I Ricci, G Rizzello, F Helwig, U Cifone, MG Campieri, M De Simone, C
Citation: S. Ulisse et al., Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment, AM J GASTRO, 96(9), 2001, pp. 2691-2699
Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study
Authors: Annese, V Andreoli, A Andriulli, A D'Inca, R Gionchetti, P Latiano, A Lombardi, G Piepoli, A Poulain, D Sendid, B Colombel, JF
Citation: V. Annese et al., Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study, AM J GASTRO, 96(8), 2001, pp. 2407-2412
Probiotics in infective diarrhoea and inflammatory bowel diseases
Authors: Gionchetti, P Rizzello, F Venturi, A Campieri, M
Citation: P. Gionchetti et al., Probiotics in infective diarrhoea and inflammatory bowel diseases, J GASTR HEP, 15(5), 2000, pp. 489-493
Medical treatment of ulcerative colitis
Authors: Campieri, M Gionchetti, P
Citation: M. Campieri et P. Gionchetti, Medical treatment of ulcerative colitis, DRUGS TODAY, 36, 2000, pp. 87-92
MCP-3 in inflammatory bowel disease
Authors: Helwig, U Lammers, KM Gionchetti, P Rizzello, F Campieri, M Uguccioni, M
Citation: U. Helwig et al., MCP-3 in inflammatory bowel disease, GUT, 47(1), 2000, pp. 155-155
Ultrasonographic findings in Crohn's disease
Authors: Arienti, V Zamboni, L Gionchetti, P Rizzello, F Campieri, M
Citation: V. Arienti et al., Ultrasonographic findings in Crohn's disease, GUT, 46(2), 2000, pp. 293-293
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
Authors: Gionchetti, P Rizzello, F Venturi, A Brigidi, P Matteuzzi, D Bazzocchi, G Poggioli, G Miglioli, M Campieri, M
Citation: P. Gionchetti et al., Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial, GASTROENTY, 119(2), 2000, pp. 305-309
Activation of the JAK-STAT system in pouchitis
Authors: Kuhbacher, T Gionchetti, P Rosenstiel, P Buhr, HJ Schreiber, S
Citation: T. Kuhbacher et al., Activation of the JAK-STAT system in pouchitis, LANG ARCH S, 1999, pp. 447-449
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - A GISC study
Authors: Annese, V Latiano, A Bovio, P Forabosco, P Piepoli, A Lombardi, G Andreoli, A Astegiano, M Gionchetti, P Riegler, G Sturniolo, GC Clementi, M Rappaport, E Fortina, P Devoto, M Gasparini, P Andriulli, A
Citation: V. Annese et al., Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - A GISC study, EUR J HUM G, 7(5), 1999, pp. 567-573
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis
Authors: Venturi, A Gionchetti, P Rizzello, F Johansson, R Zucconi, E Brigidi, P Matteuzzi, D Campieri, M
Citation: A. Venturi et al., Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis, ALIM PHARM, 13(8), 1999, pp. 1103-1108
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
Authors: Gionchetti, P Rizzello, F Venturi, A Ugolini, F Rossi, M Brigidi, P Johansson, R Ferrieri, A Poggioli, G Campieri, M
Citation: P. Gionchetti et al., Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis, ALIM PHARM, 13(6), 1999, pp. 713-718
A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial
Authors: Gionchetti, P Ardizzone, S Benvenuti, ME Porro, GB Biasco, G Cesari, P D'Albasio, G De Franchis, R Monteleone, G Pallone, F Ranzi, T Trallori, G Valpiani, D Vecchi, M Campieri, M
Citation: P. Gionchetti et al., A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial, ALIM PHARM, 13(3), 1999, pp. 381-388
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial
Authors: Gionchetti, P Rizzello, F Ferrieri, A Venturi, A Brignola, C Ferretti, M Peruzzo, S Miglioli, M Campieri, M
Citation: P. Gionchetti et al., Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial, DIG DIS SCI, 44(6), 1999, pp. 1220-1221
Relapsing ulcerative colitis after spinal cord stimulation: A case of intestinal neurogenic inflammation?
Authors: Barbara, G de Giorgio, R Stanghellini, V Gionchetti, P Campieri, M Corinaldesi, R
Citation: G. Barbara et al., Relapsing ulcerative colitis after spinal cord stimulation: A case of intestinal neurogenic inflammation?, GASTROENTY, 117(5), 1999, pp. 1256-1257
Probiotics in inflammatory bowel disease: New insight to pathogenesis or apossible therapeutic alternative?
Authors: Campieri, M Gionchetti, P
Citation: M. Campieri et P. Gionchetti, Probiotics in inflammatory bowel disease: New insight to pathogenesis or apossible therapeutic alternative?, GASTROENTY, 116(5), 1999, pp. 1246-1249
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis
Authors: Uguccioni, M Gionchetti, P Robbiani, DF Rizzello, F Peruzzo, S Campieri, M Baggiolini, M
Citation: M. Uguccioni et al., Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis, AM J PATH, 155(2), 1999, pp. 331-336
Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerativecolitis
Authors: Nielsen, OH Gionchetti, P Ainsworth, M Vainer, B Campieri, M Borregaard, N Kjeldsen, L
Citation: Oh. Nielsen et al., Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerativecolitis, AM J GASTRO, 94(10), 1999, pp. 2923-2928
Recognition of bactericidal/permeability-increasing protein by perinuclearanti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitispatients: Prevalence and clinical significance
Authors: Vecchi, M Sinico, A Bianchi, MB Radice, A Gionchetti, P Campieri, M De Franchis, R
Citation: M. Vecchi et al., Recognition of bactericidal/permeability-increasing protein by perinuclearanti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitispatients: Prevalence and clinical significance, SC J GASTR, 33(12), 1998, pp. 1284-1288
Risultati: 1-25 |